Autopsy report · NCT02801162

Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

“To much effort needed, high costs for an academic study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 7 months before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Universitair Ziekenhuis Brussel

Sponsor type

University, hospital or other

Conditions

Hypoxia; Hypercapnia; Anaemia

Interventions

conventional ABG analyser; Proxima 3®

Participants

20

Sites

1

Countries

Belgium

Trials that died the same way

• Prospective Study of Functional and Quality of Life Outcomes in Panniculectomy Patients
  “Due to complexity and cost of study (no outside funding)” (74% match in meaning)
• Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
  “Due to limited resources available to conduct study” (67% match in meaning)
• HBOT Late Radiation Tissue Injury
  “Lack of resources to complete the study” (62% match in meaning)
• RescueTEE for In-hospital Cardiac Arrest (ReTEECA Trial)
  “Not enough resources to execute study” (62% match in meaning)
• Influence of PESF on Oxygen Saturation, Quality of Life and Exercise Capacity in COPD
  “Logistical problems at study site” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.